Additionally, MYC can enhance osteoclast differentiation and bone-resorption activity by regulating transcription of glutamine transporter (Slc1a5) and glutaminase (Gls1), accelerating bone erosion in RA patients (30, 31). This evidence concerns the gene SLC1A5 and rheumatoid arthritis.